Publicly trading company, specializing in research, development, production, and distribution of solutions for Genomics, Proteomics and Diagnostics, currently developing a platform comprised of molecular human diagnostic tools for various diseases.|
Details: Acrongenomics, Inc. (OTCBB: AGNM) is a research and development nanobiotechnology company pioneering the development of uniquely advanced nanomolecular diagnostics for the Life Sciences Industry. The Company seeks to establish its proprietary nanotechnology platform as a standard in Molecular In Vitro Diagnostics.
The Company has already established an exclusive strategic alliance and also plans to collaborate with leading industry and organizations to commercialize and further grow the value of its technology worldwide.
Acrongenomics is dedicated to transforming scientific concepts into reality, as it has successfully applied Nanotechnology inspirations into next-generation Biotechnology applications.